Delivery Order SPE2DB22D3501-SPE2DB25FXM45
- Not listed
- The Defense Logistics Agency awarded a $4,002.34 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with a completion date of August 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the vendor's primary location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors valued at $6,396.78. This is a firm fixed price, non-set-aside contract with a completion date of September 17, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999...
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,540.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on August 14, 2025, with a ceiling value of $1,041.42 and an ultimate completion date of August 15, 2025. This competitive, firm fixed-price delivery order represents pharmaceutical supply to support military and federal healthcare requirements. The award is classified as a child contract, indicating it derives from a larger contract vehicle. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $1,135.11. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a small-value transaction within the pharmaceutical supply chain. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $42,662.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a non-set-aside competitive award with a completion date of August 28, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product on September 8, 2025, with a ceiling value of $15,134.80. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive role as a pharmaceutical distributor supporting...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM45Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $4,540.44 with firm fixed pricing. This competitively awarded, non-set-aside delivery order is expected to be completed by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a routine pharmaceutical procurement under the company's larger federal supply arrangement. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and the Defense Health Agency. The company's extensive federal contracting history and competitive performance across multiple therapeutic domains demonstrate its capability to fulfill the specialized pharmaceutical supply requirements of the Department of Defense and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/23/25 |